-
Zymeworks, Celgene expand bispecific antibody partnership
biospectrumasia
April 25, 2018
Zymeworks will receive an expansion fee of $164M and will be eligible to receive milestones plus royalties on all products as before.
-
Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel
worldpharmanews
March 01, 2018
Merck announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in Israel.
-
GE Healthcare, Tatweer Medical team up for advanced diagnostics
biospectrumasia
February 26, 2018
GE Healthcare and Medical Village will create a centralized Diagnostic Radiology Centre that will serve the entire development, providing sustainable high-quality diagnostics to support Medical Village in achieving clinical excellence.
-
Australian Digital Health and Life Sciences Delegation explores partnerships in India
biospectrumasia
September 05, 2017
The Australia Business Week in India features more than 50 business events and activities spread across 6 cities
-
ShangPharma Innovation enters into partnership with UCSF
biospectrumasia
July 14, 2017
The partnership helps advance a major new initiative at UCSF to bridge academic research with industrial development.
-
Metrohm & CAMO Software are announcing a global partnership
europeanpharmaceuticalreview
July 03, 2017
Optimising analysis in the laboratory with modern instruments and high-performance software…
-
CROS NT Expands Medidata Pact
contractpharma
May 26, 2017
Will offer customers Medidata’s next-gen EDC and RTSM systems
-
Lupin and Lilly expand partnership in India
pharmaasia
May 17, 2017
Exclusive licensing agreement with Eli Lilly will enable Lupin to commercialise and distribute Cialis
-
SkinCeuticals Announces Partnership With ReSurge International
en-cphi.cn
May 02, 2017
SkinCeuticals is born from science, rooted in the belief that knowledge is power, and committed to doctors in the field of skin health and aesthetics.
-
Horizon Discovery enters into R&D and licensing partnership with Amplycell S.A. for bioproduction ce
pharmasia
April 14, 2017
AmplyCell's Cell Fitness Technologies, which include BOOST, consist of a four-stage process to optimise cell lines in terms of stability and productivity.